case 2: molecular risk stratification in myeloma
Published 5 years ago • 73 plays • Length 6:50Download video MP4
Download video MP3
Similar videos
-
3:59
case 2: determining risk in myeloma
-
2:43
case 2: evolution of molecular testing in myeloma
-
4:41
case 2: overcoming high risk in myeloma
-
5:50
case 2: mrd negativity in high-risk myeloma
-
2:42
case review: mm with high-risk cytogenetics
-
1:57
using molecular abnormalities for risk stratification in multiple myeloma at the time of diagnosis
-
4:41
case 2: the role of maintenance therapy in myeloma
-
3:13
case review: standard-risk multiple myeloma
-
1:44
risk assessment of multiple myeloma
-
3:23
a case of high-risk multiple myeloma
-
3:58
case 1: molecular testing in myeloma
-
4:59
case 3: molecular testing in relapsed myeloma
-
0:24
risk stratification for mgus | dr. s. vincent rajkumar | oncology brothers
-
3:01
diagnosis of stage 2 multiple myeloma
-
4:32
case-based overview: newly diagnosed multiple myeloma
-
4:09
case 1: consolidation therapy in myeloma
-
4:25
management of high-risk multiple myeloma
-
5:04
the pangea model: improving risk stratification in multiple myeloma
-
2:17
a look at mutations in patients with high-risk multiple myeloma